期刊文献+

环磷腺苷葡胺预处理对瓣膜置换术患者心肌的保护作用 被引量:9

Myocardial protective effect of meglumine adenosine cyclophosphate preconditioning in patients undergoing cardiac valve replacement with cardiopulmonary bypass
下载PDF
导出
摘要 目的评价环磷腺苷葡胺预处理对瓣膜置换术患者心肌的保护作用。方法择期行体外循环心脏瓣膜置换术患者60例,性别不限,年龄28-64岁,ASA分级Ⅱ级或Ⅲ级,心功能分级Ⅱ级或Ⅳ级,随机分为对照组(c组)和环磷腺苷葡胺预处理组(M组)各30例。M组在麻醉诱导后从颈内静脉输注环磷腺苷葡胺2mg/kg,C组给予等量生理盐水。于麻醉诱导前(T0,基础状态)、主动脉开放后30min(T1)、术后6h(T2)、24h(T3)记录两组患者HR、MAP、CVP等血流动力学指标,并取静脉血测定心肌肌钙蛋白I(cTnI)浓度和肌酸激酶同工酶(CK-MB)活性;术前1d和术后7d行心脏彩超了解患者左心室射血分数(LVEF)、心脏指数(CI)。结果与c组比较,M组主动脉开放后各时点血流动力学指标差异无统计学意义(P〉0.05),cTnI浓度和CK-MB活性降低(P〈0.05)。两组间LVEF和CI术前比较差异无统计学意义(P〉0.05),术后7d时M组LVEF和cI高于C组(P〈0.05)。结论环磷腺苷葡胺预处理有利于瓣膜置换术患者左心功能的恢复,具有心肌保护作用,其机制可能与降低cTnI浓度和CK.MB活性有关。 Objective To evaluate the myocardial protective effect of meglumine adenosine cyclophosphate (MAC) preconditioning in patients undergoing cardiac valve replacement with cardiopulmonary bypass. Methods Six- ty patients (ASA grade II or IV, NYHA class 1I or llI), aged 28-64, scheduled for cardiac valve replacement with car- diopulmonary bypass, were randomly divided into control group (group C) and MAC preconditioning group (group M) (n=30 each). In group M, MAC 2 mg/kg was infused via central vein after induction of anesthesia. In group C same volume normal saline was infused instead of MAC. HR, MAP and CVP were determined, and blood samples were obtained for determination of plasma concentrations of cardiac troponin-I (cTnI) and activities of CK-MB before induction of anesthesia (To, baseline), at 30 min after aortic unclamping (%) and at 6 h (T2), 24 h (%) after operation. Left ventricular EF and CI were measured before operation and at 7 days after operation. Results There was no significant difference in the hemodynamic parameters between the two groups. The plasma concentrations of cTnI and activity of CK-MB were significantly lower, at 30 min after aortic unclamping and at 6 h, 24 h after operation in group M than those in group C (P〈0.05). LVEF and CI between two groups were not significantly different before surgery. LVEF and CI were significantly higher at 7 days after operation in group M than those in group C (P〈0.05). Conclusion MAC precondition can recover cardiac function and protect myocardium, which mechanism is related to decreasing the plasma concentrations of cTnI and the activity of CK-MB.
出处 《海南医学》 CAS 2013年第1期20-22,共3页 Hainan Medical Journal
关键词 环磷腺苷葡胺 预处理 体外循环 心肌保护 Meglumine adenosine cyclophosphate Preconditioning Cardiopulmonary bypass Myocardial protection
  • 相关文献

参考文献9

  • 1卢彬,李强.参附注射液在体外循环中对心肌的保护作用[J].海南医学,2009,20(1):25-26. 被引量:2
  • 2樊启明.环磷腺苷葡胺治疗慢性充血性心力衰竭疗效观察[J].海南医学,2008,19(11):101-101. 被引量:8
  • 3涂杰,张炳东,吕静,梁东科,李涛.不同羟乙基淀粉对心肺转流血液循环和凝血功能的影响[J].海南医学,2011,22(24):21-24. 被引量:2
  • 4Badruzzaman M, Hossaim A, Adhikary AB, et al. Evaluation ofmyocardial protection in off-pump vs. on-pump coronary bypasssurgery by troponin I estimation [J]. Bangladesh Med Res CouncBull, 2010,36(3): 93-96.
  • 5Wei-hua L, Jun-yu H, Chang-qing S, et al. Study on the relationshipof Cpla2, CK-MB, and membrane phospholipid content in acutemyocardial infarction [J]. Heart Vessels, 2011,26(1): 64-68.
  • 6罗书红.环磷腺苷葡胺治疗扩张型心肌病30例疗效观察[J].海南医学,2010,21(5):34-35. 被引量:6
  • 7Langeron O. Voluven, a lower substituted novel hydroxyethyl starch(HES 130/0.4), causes fewer effects on coagulation in major ortho-pedic surgery than HES 200/0.5 [J]. Anesth Analg, 2001,92(2):855-862.
  • 8Okumura S, Vatner DE, Kurotani R, et al. Disruption of type 5 ade-nylyl cyclase enhances desensitization of cyclic adenosine mono-phosphate signal and increases Akt signal with chronic catechol-amine stress [J]. Circulation, 2007, 116(16): 1776-1783.
  • 9Lewin G, Matus M, Basu A, et al. Critical role of transcription factorcyclic AMP response element modulator in beta 1 -adrenoceptor-medi-ated cardiac dysfunction [J]. Circulation, 2009,119(1): 79-88.

二级参考文献24

共引文献14

同被引文献68

  • 1吴勤英,罗玉寅.卡托普利联合环磷腺苷葡胺对老年慢性心力衰竭患者血清C-反应蛋白的影响[J].中国老年学杂志,2014,34(2):326-327. 被引量:18
  • 2LU Feng,JI Bing-yang,LIU Jin-ping,LIU Ming-zheng,WANG Gu-yan,HU Sheng-shou.Passive graft perfusion in off-pump coronary artery bypass grafting[J].Chinese Medical Journal,2007(3):192-196. 被引量:6
  • 3李军朋,王云.心肌缺血再灌注损伤临床防治新进展[J].医学研究杂志,2007,36(3):17-19. 被引量:6
  • 4Nordlie MA, Wold LE, Simkhovich BZ, et al. Molecular aspects of ischemic heart disease:ischemia/reperfusion induced geneticchang- es and potential appliticions of gene and RNA interference therapy [Y]. Cardiovasc Pharmaco Ther, 2006, 11(1): 17-30.
  • 5Yamazaki S, Toyokuni S, et al. Effect ofedaravone,a novel free radi- cal scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart [J]. Heart Vessels, 2009, 24(3): 228-235.
  • 6Massoudy P, Zahler S, Becket BF, et al. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with c ardiopulmonary bypass [J]. Chest, 2001, 119(1): 31-36.
  • 7Albacker T, Carvalho C, Schricker T, et at. High-does insulin thera- py attenustes systemic inflammatory response in coronary artery by- pass grafting patients [J]. Ann Thorac Surg, 2008, 86(1): 20-27.
  • 8Harmon D, Coleman E, Mrshall C, et al. The effect of clomethia- zole on plasma concentrations of interleukin-6,-8,-1 beta, tumor ne- crosis factor-alpha, and neutrophil adhesion molecule expression during, experimental extracorporeal circulation [J]. Anesth Analg, 2003, 97(1): 13-18.
  • 9Reyes YA, Shimoyama T, Akamatsu H, et al. MCI-186(edaravone), a flee radical scavenger,attenuates ischemia-reperfusion injury and activation of phospholipase A(2) in an isolated rat lung model after 18h of cold preservation [J]. Eur J Cardiothorac Surg, 2006, 29(3): 304-311.
  • 10Masjtffm J, .lvarez-Sabfn J, Blaaco M, et al. Current management of anfithrombofic treatment in patients with non valvular atrial fibril- lation and prior history of stroke or transient ischemic attack [J]. Rev Neurol, 2014, 59(1): 25-36.

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部